Altitude Crest Partners Inc.

SEC CIK: 0001986035
Latest filing: Feb 14, 2025

SEC filings (opens in a new tab)

APLS holding history

Apellis Pharmaceuticals, Inc. in every 13F filed by Altitude Crest Partners Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

APLS overview All 13F holders of APLS Full Q4 2024 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of APLS by Altitude Crest Partners Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−287,277−100.0%	Sold out	Holders
Q1 2024	287,277	$16.9M	7.2%	+135,077+88.7%	Added	Holders
Q4 2023	152,200	$9.11M	6.1%	–	No prior filing	Holders